Outcomes of Older Patients with Non-Metastatic Breast Cancer Treated with Primary Hormonal Therapy

被引：0
|
作者：
Koh, S. W. [1 ]
Morrogh, M. [1 ]
Corrigan, M. [1 ]
Kelly, L. [1 ]
O'Sullivan, M. J. [1 ]
Quinn, E. M. [1 ]
机构：
[1] Cork Univ Hosp, Breast Surg, Cork, Ireland
来源：
IRISH JOURNAL OF MEDICAL SCIENCE | 2022年 / 191卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
5
引用
收藏
页码：S208 / S208
页数：1
相关论文
共 50 条
  • [1] The long term outcomes of female patients treated with primary endocrine therapy for non-metastatic breast cancer
    Morrow, E.
    Griffard, A.
    Murray, J.
    Lannigan, A.
    CANCER RESEARCH, 2017, 77
  • [2] A study of the long term outcomes of patients treated with primary endocrine therapy for non-metastatic breast cancer.
    Morrow, E. S.
    Griffard, A.
    Murray, J.
    BRITISH JOURNAL OF SURGERY, 2016, 103 : 139 - 140
  • [3] Low incidence of distant metastases in older women with non-metastatic breast cancer treated with primary endocrine therapy
    Kostev, Karel
    Kalder, Matthias
    BREAST CANCER RESEARCH AND TREATMENT, 2024, 203 (01) : 181 - 182
  • [4] Low incidence of distant metastases in older women with non-metastatic breast cancer treated with primary endocrine therapy
    Karel Kostev
    Matthias Kalder
    Breast Cancer Research and Treatment, 2024, 203 : 181 - 182
  • [5] Prognostic factors among elderly patients with operable non-metastatic breast cancer treated with primary endocrine therapy
    Rocha, Erika Andrade
    Vasconcellos, Jessica Monteiro
    Mendes, Sofia Vidaurre
    Freire, Pedro Jose Galvao
    Messias, Ana Paula
    Leis, Leticia Vecchi
    Moreira, Otavio Noschang
    Pereira, Mauricio Baptista
    Orsi, Bruna Zanin
    Araujo Neto, Augusto
    Petry, Vanessa
    Bonadio, Renata Colombo
    Testa, Laura
    CANCER RESEARCH, 2023, 83 (05)
  • [6] Tamoxifen pharmacokinetics and pharmacodynamics in older patients with non-metastatic breast cancer
    Souwer, E. T. D.
    Sanchez-Spitman, A.
    Moes, D. J. A. R.
    Gelderblom, H.
    Swen, J. J.
    Portielje, J. E. A.
    Guchelaar, H. J.
    van Gelder, T.
    BREAST CANCER RESEARCH AND TREATMENT, 2023, 199 (03) : 471 - 478
  • [7] Tamoxifen pharmacokinetics and pharmacodynamics in older patients with non-metastatic breast cancer
    E. T. D. Souwer
    A. Sanchez-Spitman
    D. J. A. R. Moes
    H. Gelderblom
    J. J. Swen
    J. E. A. Portielje
    H. J. Guchelaar
    T. van Gelder
    Breast Cancer Research and Treatment, 2023, 199 : 471 - 478
  • [8] Non-metastatic breast cancer
    Saglier, J
    JOURNAL DE CHIRURGIE, 2005, 142 (06): : 355 - 366
  • [9] The impact of geriatric characteristics and comorbidities on distant metastases and other cause mortality in older women with non-metastatic breast cancer treated with primary endocrine therapy
    Waaijer, M. E. C.
    Lemij, A. A.
    de Boer, A. Z.
    Bastiaannet, E.
    van den Bos, F.
    Derks, M. G. M.
    Kroep, J. R.
    Liefers, G. J.
    Portielje, J. E. A.
    de Glas, N. A.
    BREAST CANCER RESEARCH AND TREATMENT, 2023, 201 (03) : 471 - 478
  • [10] The impact of geriatric characteristics and comorbidities on distant metastases and other cause mortality in older women with non-metastatic breast cancer treated with primary endocrine therapy
    M. E.C. Waaijer
    A. A. Lemij
    A. Z. de Boer
    E. Bastiaannet
    F. van den Bos
    M. G.M. Derks
    J. R. Kroep
    G. J. Liefers
    J. E.A. Portielje
    N. A. de Glas
    Breast Cancer Research and Treatment, 2023, 201 : 471 - 478
12345